Scarica l'app Stockscreener
2.24
4.27%
-0.10
Dopo l'orario di chiusura:
2.20
-0.04
-1.79%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PACB Giù?
Forum
Previsione
Precedente Chiudi:
$2.34
Aprire:
$2.34
Volume 24 ore:
11.55M
Relative Volume:
1.48
Capitalizzazione di mercato:
$672.83M
Reddito:
$188.87M
Utile/perdita netta:
$-400.38M
Rapporto P/E:
-1.4933
EPS:
-1.5
Flusso di cassa netto:
$-260.90M
1 W Prestazione:
+7.18%
1M Prestazione:
+50.34%
6M Prestazione:
+98.23%
1 anno Prestazione:
-8.20%
Intervallo 1D:
$2.16
$2.34
Intervallo di 1 settimana:
$1.91
$2.37
Portata 52W:
$0.8511
$2.72
Pacific Biosciences Of California Inc Stock (PACB) Company Profile
Nome
Pacific Biosciences Of California Inc
Settore
Industria
Telefono
650-521-8000
Indirizzo
1305 O'BRIEN DRIVE, MENLO PARK, CA
Confronta PACB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PACB
Pacific Biosciences Of California Inc
|
2.24 | 702.87M | 188.87M | -400.38M | -260.90M | -1.50 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Pacific Biosciences Of California Inc Stock (PACB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-11 | Downgrade | UBS | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Buy |
| 2024-04-22 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-04-18 | Downgrade | Goldman | Buy → Neutral |
| 2023-12-14 | Iniziato | Guggenheim | Neutral |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-11-17 | Aggiornamento | UBS | Neutral → Buy |
| 2023-10-31 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-06-30 | Iniziato | Goldman | Buy |
| 2023-05-10 | Iniziato | Barclays | Equal Weight |
| 2023-03-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2023-01-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-01-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2022-01-06 | Ripresa | Piper Sandler | Neutral |
| 2021-10-15 | Ripresa | Cowen | Market Perform |
| 2021-09-27 | Iniziato | Canaccord Genuity | Buy |
| 2021-02-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-11-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-10-02 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-02 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-03-09 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-10-15 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-04-02 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2018-10-19 | Iniziato | Cowen | Outperform |
| 2017-11-03 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-28 | Downgrade | CL King | Buy → Neutral |
| 2016-11-03 | Reiterato | Cantor Fitzgerald | Buy |
| 2016-06-27 | Iniziato | CL King | Buy |
| 2016-04-15 | Iniziato | First Analysis Sec | Overweight |
| 2016-02-04 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2016-01-04 | Reiterato | Cantor Fitzgerald | Buy |
| 2015-10-23 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2015-08-27 | Iniziato | Cantor Fitzgerald | Buy |
| 2015-02-04 | Reiterato | Maxim Group | Buy |
| 2013-09-26 | Reiterato | Maxim Group | Buy |
| 2013-01-14 | Reiterato | Maxim Group | Buy |
Mostra tutto
Pacific Biosciences Of California Inc Borsa (PACB) Ultime notizie
PacBio Earnings: What To Look For From PACB - Yahoo! Finance UK
Pacific Biosciences of California Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Pacific Biosciences of California showcases live Vega demos at AMP 2025 - Traders Union
How to build a custom watchlist for Pacific Biosciences of California Inc.July 2025 Pullbacks & Weekly Chart Analysis and Guides - newser.com
Will Pacific Biosciences of California Inc. stock recover after recent dropTake Profit & Real-Time Chart Breakout Alerts - newser.com
Is Pacific Biosciences of California Inc. stock ready for a breakoutIPO Watch & Stepwise Entry and Exit Trade Signals - newser.com
Is Pacific Biosciences of California Inc. stock a top pick in earnings seasonTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Analyzing recovery setups for Pacific Biosciences of California Inc. investors2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Smart tools for monitoring Pacific Biosciences of California Inc.’s price action2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Price action breakdown for Pacific Biosciences of California Inc.July 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com
Statistical indicators supporting Pacific Biosciences of California Inc.’s strengthProduct Launch & Verified High Yield Trade Plans - newser.com
Is Pacific Biosciences of California Inc. (P09) stock resilient in recession scenariosWatch List & Trade Opportunity Analysis - newser.com
Can Pacific Biosciences of California Inc. stock resist market sell offsWeekly Market Report & Safe Capital Growth Tips - newser.com
Does Pacific Biosciences of California Inc. stock trade at a discount to peersJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - newser.com
Why Pacific Biosciences of California Inc. stock is favored by top institutionsJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Will Pacific Biosciences of California Inc. continue its uptrend2025 Fundamental Recap & Real-Time Market Sentiment Alerts - newser.com
Is Pacific Biosciences of California Inc. (P09) stock a buy before new product rolloutJobs Report & AI Driven Stock Reports - newser.com
Will Pacific Biosciences of California Inc. stock split attract more investorsTrade Risk Assessment & Weekly High Momentum Picks - newser.com
Custom strategy builders for tracking Pacific Biosciences of California Inc.July 2025 Patterns & Free Community Consensus Stock Picks - newser.com
What makes Pacific Biosciences of California Inc. stock attractive to growth fundsEarnings Overview Summary & Expert Approved Momentum Ideas - newser.com
Will Pacific Biosciences of California Inc. stock sustain high P E ratios2025 Growth vs Value & Scalable Portfolio Growth Methods - newser.com
What analysts say about Pacific Biosciences of California Inc P09 stockAutomated Trading Signals & Small Capital Wealth Plans - earlytimes.in
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap UpHere's What Happened - MarketBeat
Pacific Biosciences of California (NASDAQ:PACB) Shareholders Are up 16% This Past Week, but Still in the Red Over the Last Five Years - 富途牛牛
Carret Asset Management LLC Buys New Holdings in Pacific Biosciences of California, Inc. $PACB - MarketBeat
Pacific Biosciences of California, Inc. (PACB) latest stock news and headlines - Yahoo! Finance UK
ARK’s PACB Share Buy: Could Institutional Confidence Signal a Turning Point for Pacific Biosciences? - Yahoo Finance
Pacific Biosciences of California emphasizes advanced research initiatives - Traders Union
PacBio (PACB) Shares Skyrocket, What You Need To Know - Yahoo Finance
Can Pacific Biosciences of California Inc. stock deliver strong Q4 earningsMarket Performance Recap & Community Consensus Stock Picks - newser.com
How resilient is Pacific Biosciences of California Inc. stock in market downturns2025 Geopolitical Influence & AI Forecast for Swing Trade Picks - newser.com
Ranking Pacific Biosciences of California Inc. among high performing stocks via toolsEntry Point & Stock Market Timing Techniques - newser.com
Pacific Biosciences Of California Inc Azioni (PACB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.84%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):